Malaria Clinical Trial Pipeline – Global Forecast to 2024 – ResearchAndMarkets.com

June 7, 2019 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global
Malaria Clinical Trial Pipeline Highlights – 2019”
report has
been added to ResearchAndMarkets.com’s offering.

Malaria Pipeline Highlights – 2019, provides most up-to-date information
on key pipeline products in the global Malaria market. It covers
emerging therapies for Malaria in active clinical development stages
including early and late stage clinical trials. The pipeline data
presented in this report helps executives for tracking competition,
identifying partners, evaluating opportunities, formulating business
development strategies, and executing in-licensing and out-licensing
deals.

Clinical Trial Stages:

The report provides Malaria pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.

Drug Mechanism Classes:

The report provides Malaria pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.

Company:

The report provides Malaria pipeline products by the company.

Short-term Launch Highlights:

Find out which Malaria pipeline products will be launched in the US and
Ex-US till 2024.

Summary:

  • Malaria phase 3 clinical trial pipeline products
  • Malaria phase 2 clinical trial pipeline products
  • Malaria phase 1 clinical trial pipeline products
  • Malaria preclinical research pipeline products
  • Malaria discovery stage pipeline products
  • Malaria pipeline products short-term launch highlights

Key Topics Covered:

1. Malaria Pipeline by Stages

2. Malaria Phase 3 Clinical Trial Insights

3. Malaria Phase 2 Clinical Trial Insights

4. Malaria Phase 1 Clinical Trial Insights

5. Malaria Preclinical Research Insights

6. Malaria Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/gg5uj9

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]

For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related
Topics: Infectious
Diseases Drugs
, Clinical
Trials